Your browser doesn't support javascript.
loading
Protocol for high-throughput cloning, expression, purification, and evaluation of bispecific antibodies.
Li, Danqing; Partin, Alexander C; Zhao, Liangjun; Chen, Irwin; Michaels, Mark L; Wang, Zhulun; Garces, Fernando; Gong, Danyang; Riley, Timothy P.
Afiliação
  • Li D; Department of Therapeutics Discovery, Amgen Research, Amgen Inc., Thousand Oaks, CA 91320, USA.
  • Partin AC; Department of Therapeutics Discovery, Amgen Research, Amgen Inc., Thousand Oaks, CA 91320, USA.
  • Zhao L; Department of Therapeutics Discovery, Amgen Research, Amgen Inc., Thousand Oaks, CA 91320, USA.
  • Chen I; Department of Therapeutics Discovery, Amgen Research, Amgen Inc., San Francisco, CA 94080, USA.
  • Michaels ML; Department of Therapeutics Discovery, Amgen Research, Amgen Inc., Thousand Oaks, CA 91320, USA.
  • Wang Z; Department of Therapeutics Discovery, Amgen Research, Amgen Inc., Thousand Oaks, CA 91320, USA.
  • Garces F; Department of Therapeutics Discovery, Amgen Research, Amgen Inc., Thousand Oaks, CA 91320, USA.
  • Gong D; Department of Therapeutics Discovery, Amgen Research, Amgen Inc., Thousand Oaks, CA 91320, USA.
  • Riley TP; Department of Therapeutics Discovery, Amgen Research, Amgen Inc., Thousand Oaks, CA 91320, USA.
STAR Protoc ; 3(2): 101428, 2022 06 17.
Article em En | MEDLINE | ID: mdl-35664258
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anticorpos Biespecíficos Tipo de estudo: Guideline Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anticorpos Biespecíficos Tipo de estudo: Guideline Idioma: En Ano de publicação: 2022 Tipo de documento: Article